峰瑞资本
@author-1781068851320
504 articles
What Are the Aesthetic Roots Behind China's Potential to Birth Luxury Brands? | 2021 FreeS Fund Annual Investor Summit
"Can China Have Luxury Brands?"
峰瑞资本·
As Long as You Don't Lose the Domestic Race, You'll Win Globally | Li Feng's New Year Outlook on Consumption
7 Defining Factors That Will Shape the Consumer Market Over the Next Decade
峰瑞资本·
What Kind of Spiritual Consumption Does Gen Z Need? | 2021 FreeS Fund Annual Investor Summit
What kind of consumer group is Gen Z?
峰瑞资本·
How Do Tech Companies Go From "Technology Is Valuable" to "Technology Makes Money"? | FreeS Research --- In the past two years, the tech industry has undergone a profound shift. The era of "technology for technology's sake" is fading. Companies that once commanded sky-high valuations based on technical prowess alone are now facing a harsh reality: investors and markets increasingly demand proof that technology can translate into sustainable profits. This transition—from "technology is valuable" to "technology makes money"—is far from automatic. It requires fundamental changes in how tech companies think about product-market fit, commercialization strategy, and organizational capabilities. ## The Valuation Trap For years, Chinese tech companies were rewarded for technical milestones. Breakthroughs in AI, quantum computing, or autonomous driving could attract hundreds of millions in funding before a single revenue dollar was earned. The underlying assumption: superior technology would inevitably find commercial applications. This logic has collapsed on multiple fronts. Some technologies proved to be solutions in search of problems. Others faced regulatory headwinds that made their intended business models unviable. Still others discovered that the cost of commercial deployment far exceeded initial projections, rendering unit economics untenable. The result is a growing cohort of "zombie unicorns
Why should tech talent avoid "walking around with a hammer looking for nails"?
峰瑞资本·
How to Capture Category Dividends in Consumer Entrepreneurship? | FreeS Research
How to Lead the Pack?
峰瑞资本·
3 Biopharma Companies Raise Over 1 Billion Yuan Combined | FreeS Family Funding News · October–November
Firmly bullish on the development of biomedical innovation in China
峰瑞资本·
What Infrastructure Opportunities Exist in the Booming Cross-Border E-Commerce Space? | FreeS Fund Interview
How do you find the right startup opportunity in a fast-growing sector?
峰瑞资本·
"There Will Come a Moment When Technology Defeats Human Experience" | A Conversation with FreeS Fund
"There will come a moment when technology surpasses human experience."
峰瑞资本·
FreeS Fund Earns Ten Honors from Zero2IPO, PEDaily, ChinaVenture & GEW, CVCRI, ChinaRong360, Wanbang RB, and Lancha Consumer | FreeS Matters
Continuously hiring investors
峰瑞资本·
Expansion or Store Closures: Reassessing Offline Opportunities | Li Feng Column
From "Store Opening Boom" to "Store Closing Wave": Reassessing Offline Opportunities
峰瑞资本·
Live at 10 AM Tomorrow | New Opportunities in the Changing Landscape of Drug R&D
See you tomorrow at 10 a.m. sharp.
峰瑞资本·
How Should We Think About the Present and Future of Drug R&D? | FreeS Fund Dialogue Vol. 2 — Final 2 Days to Register
What new variables and opportunities are emerging in the drug development industry?
峰瑞资本·